Researchers report that a specific immune cell type—gamma delta T cells—can recognize and destroy small-cell lung cancer. The studies describe the cells as able to detect tumour cells and help drive better outcomes, including in patients with higher levels of these immune cells.
One outlet highlights a WEHI-led study, adding that pre-existing treatments may be able to further strengthen the immune cells’ cancer-fighting activity and linking higher gamma delta T-cell levels with improved survival. Another outlet frames the work more broadly, emphasizing that this “hidden” immune defense can attack despite tumors’ efforts to evade conventional immune detection. Together, the sources focus on immune recognition and potential ways to enhance therapy, while describing small-cell lung cancer as particularly aggressive and difficult to treat.
